Level A· Stronger Clinical EvidenceMeta-analysisEurope PMCOpen access

Efficacy and safety of stem cell therapy in patients with chronic lower extremity ulcers: an umbrella review of systematic reviews and meta-analyses

Wang HF., Lin Z., Ma CX., Liu S., Cao Y., Li QS.

Meta-analysis on Chronic Wound, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.

Open my reading list
Level A· Stronger Clinical EvidenceEvidence level of this study

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Meta-analysis
Journal
Stem Cell Res Ther (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41422233
PMCID
PMC12831329
DOI
10.1186/s13287-025-04853-x

Abstract (original English)

Background Chronic lower extremity ulcers (CLEUs) remain a major clinical challenge due to their prolonged healing process and risk of amputation. Stem cell therapy (SCT) has emerged as a promising regenerative strategy, with various cell types being explored for their efficacy in treating CLEUs. This umbrella review aims to consolidate the existing evidence on stem cell interventions for CLEUs, providing a comprehensive overview of the current research landscape. Methods This umbrella review was conducted following the PRIOR and PRISMA guidelines. We searched across PubMed, Embase, Web of Science, and Cochrane Library databases for systematic reviews (SRs) and meta-analyses (MAs) that included randomized controlled trials (RCTs) on SCT for CLEUs. The methodological quality and evidence quality of the SRs/MAs were assessed by AMSTAR 2 and GRADE. A quantitative synthesis of all RCTs included in the SRs/MAs to obtain objective and updated conclusions. Results A total of 28 SRs/MAs involving 72 RCTs were included. Our updated meta-analysis reinforces that SCT offers potential therapeutic benefits for CLEUs, including improved healing rates, amelioration of tissue perfusion and pain-related indicators, and more favorable prognostic outcomes. No significant difference in all-cause mortality was observed between the SCT and control groups. Conclusion SCT represents a promising adjunc

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

How we grade evidence
Lower ExtremityHumansLeg UlcerChronic DiseaseStem Cell TransplantationWound HealingRandomized Controlled Trials as Topic

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research